Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Analysing changes in the pharmaceutical industry

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.05.12
Views: 3051

Dr Siegfried Bialojan – Ernst and Young, Germany

Dr Siegfried Bialojan talks to ecancer about improving health outcomes at the European Forum on Oncology in Berlin, May 2012.


Analysing changes in the pharmaceutical industry, Dr Bialojan says that pharmaceutical companies need to shift from only selling drugs to improving health outcomes in patients. Three aims companies’ should strive for are understanding patient data in different ways, collaborating more with non-traditional partners and altering their business model to focus more on service.

Related videos

follow us

SIOG e-learning July 2017

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation